Arquivo para January 25th, 2021

Vaccine: Efficacy and Efficiency

25 Jan

The effectiveness of the vaccine basically depends on the action that it can take on the virus in specific people and populations, as for the age, the physical type and the organic development of each person and certain comorbidities, diseases that collaborate with the infectious process.

The fact that a vaccine is 90% effective, for example, for it to be efficient, it would be necessary to vaccinate at least 56% of the population, where the development of the virus would be limited to contagion and infectious rates would drop until the end of the pandemic in a given period, and also the vaccination time is important and the availability of the vaccine for a percentage of the population dependent on its effectiveness depends on it.

The problem is that rich countries are having inputs to produce the vaccine, so they may be more likely to fight the pandemic, the poorer countries beyond this availability, which depends on the agility of governmental actions, need to have resources for purchasing inputs. to produce vaccines in their own country or buy vaccines.

There is a market dispute and also at the political level, WHO itself said that a moral problem could occur if the poorest countries have difficulties in obtaining the vaccine and / or the inputs to produce it.

The capacity of the hospital system and the organization of the health system is also an efficiency problem, Brazil has a good public organization in the SUS system, however there is an urgency for the state’s actions, the return of the disease to a critical phase was not so there is a big problem of efficiency in the response to the disease, the lack of oxygen in Manaus was this.

Finally, there is a cultural problem, which is the understanding that we have not yet emerged from Pandemic and any measure that favors the end of isolation is worrying and this has led to an exhaustion of the hospital’s capacity to respond to the new critical phase of Pandemic.